[1]
Alvarez-Sabin J, Maisterra O, Santamarina E, et al. Factors influencing haemorrhagic transformation in ischaemic stroke. Lancet Neurol 2013; 12(7): 689-705.
[2]
Yaghi S, Willey JZ, Cucchiara B, et al. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2017; 48(12): e343-61.
[3]
Wu S, Wu B, Liu M, et al. Stroke in China: Advances and challenges in epidemiology, prevention, and management. Lancet Neurol 2019; 18(4): 394-405.
[4]
Rothwell PM, Algra A, Amarenco P. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet 2011; 377(9778): 1681-92.
[5]
Bang OY, Saver JL, Liebeskind DS, et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 2007; 68(10): 737-42.
[6]
D’Amelio M, Terruso V, Famoso G, et al. Cholesterol levels and risk of hemorrhagic transformation after acute ischemic stroke. Cerebrovascular diseases (Basel, Switzerland) 2011; 32(3): 234-8.
[7]
Kim BJ, Lee SH, Ryu WS, et al. Low level of low-density lipoprotein cholesterol increases hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism. Stroke 2009; 40(5): 1627-32.
[8]
Lin TC, Lin YK, Chen CI, et al. Serum lipid level is not associated with symptomatic intracerebral hemorrhage after intravenous thrombolysis for acute ischemic stroke. PeerJ 2018; 6: e6021.
[9]
Messe SR, Pervez MA, Smith EE, et al. Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke. Stroke 2013; 44(5): 1354-9.
[10]
Nardi K, Leys D, Eusebi P, et al. Influence of lipid profiles on the risk of hemorrhagic transformation after ischemic stroke: Systematic review. Cerebrovasc Dis Extra 2011; 1(1): 130-41.
[11]
Kannel WB. Risk stratification of dyslipidemia: Insights from the Framingham Study. Curr Med Chem Cardiovasc Hematol Agents 2005; 3(3): 187-93.
[12]
Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007; 357(13): 1301-10.
[13]
Nicholls SJ, Tuzcu EM, Sipahi I, et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 2007; 297(5): 499-508.
[14]
Lei C, Wu B, Liu M, et al. Totaled health risks in vascular events score predicts clinical outcomes in patients with cardioembolic and other subtypes of ischemic stroke. Stroke 2014; 45(6): 1689-94.
[15]
Aho K, Harmsen P, Hatano S, et al. Cerebrovascular disease in the community: Results of a WHO collaborative study. Bull World Health Organ 1980; 58(1): 113-30.
[16]
Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: A clinical examination scale. Stroke 1989; 20(7): 864-70.
[17]
Tan S, Wang D, Liu M, et al. Frequency and predictors of spontaneous hemorrhagic transformation in ischemic stroke and its association with prognosis. J Neurol 2014; 261(5): 905-12.
[18]
Choi KH, Park MS, Kim JT, et al. The serum ferritin level is an important predictor of hemorrhagic transformation in acute ischaemic stroke. Eur J Neurol 2012; 19(4): 570-7.
[19]
Tan G, Lei C, Hao Z, et al. Liver function may play an uneven role in haemorrhagic transformation for stroke subtypes after acute ischaemic stroke. Eur J Neurol 2016; 23(3): 597-604.
[20]
Liu B, Wang D, Hao Z, et al. Reduction in Estimated Glomerular Filtration Rate (eGFR) results in an increased risk of spontaneous hemorrhagic transformation in patients with large-artery atherosclerosis stroke. Curr Neurovasc Res 2016; 13(1): 75-81.
[21]
Lokeskrawee T, Muengtaweepongsa S, Patumanond J, et al. Prediction of symptomatic intracranial hemorrhage after intravenous thrombolysis in acute ischemic stroke: The symptomatic intracranial hemorrhage score. J Stroke Cerebrovasc Dis 2017; 26(11): 2622-9.
[22]
Kalinin MN, Khasanova DR, Ibatullin MM. The hemorrhagic transformation index score: A prediction tool in middle cerebral artery ischemic stroke. BMC Neurol 2017; 17(1): 177.
[23]
Zhang J, Yang Y, Sun H, et al. Hemorrhagic transformation after cerebral infarction: Current concepts and challenges. Annals of translational medicine 2014; 2(8): 81.
[24]
Lin SF, Chao AC, Hu HH, et al. Low cholesterol levels increase symptomatic intracranial hemorrhage rates after intravenous thrombolysis: A multicenter cohort validation study. J Atheroscler Thromb 2018; 26(6): 513-27.
[25]
Hong CT, Chiu WT, Chi NF, et al. Low-density lipoprotein level on admission is not associated with postintravenous thrombolysis intracranial hemorrhage in patients with acute ischemic stroke. J Investig Med 2018; 67(3): 659-62.
[26]
You S, Zhong C, Xu J, et al. LDL-C/HDL-C ratio and risk of all-cause mortality in patients with intracerebral hemorrhage. Neurol Res 2016; 38(10): 903-8.
[27]
Thrift A, McNeil J, Donnan G. Reduced frequency of high cholesterol levels among patients with intracerebral haemorrhage. J Clin Neurosci 2002; 9(4): 376-80.
[28]
Presta V, Figliuzzi I, Miceli F, et al. Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy. Atherosclerosis 2019; 285: 40-8.
[29]
Guedeney P, Claessen BE, Kalkman DN, et al. Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention. J Am Coll Cardiol 2019; 73(19): 2401-9.
[30]
Calabresi L, Gomaraschi M, Simonelli S, et al. HDL and atherosclerosis: Insights from inherited HDL disorders. Biochim Biophys Acta 2015; 1851(1): 13-8.
[31]
Rosenson RS, Shott S, Tangney CC. Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: Triglycerides and blood viscosity. Atherosclerosis 2002; 161(2): 433-9.
[32]
Millan J, Pinto X, Munoz A, et al. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag 2009; 5: 757-65.
[33]
Zeng N, Wang A, Xu T, et al. Co-effect of serum Galectin-3 and high-density lipoprotein cholesterol on the prognosis of acute ischemic stroke. J Stroke Cerebrovasc Dis 2019; 28(7): 1879-85.
[34]
Jickling GC, Liu D, Stamova B, et al. Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab 2014; 34(2): 185-99.
[35]
Song Q, Li Y, Wang Y, et al. Increased neutrophil-to-lymphocyte ratios are associated with greater risk of hemorrhagic transformation in patients with acute ischemic stroke. Curr Neurovasc Res 2018; 15(4): 326-35.
[36]
Kapourchali FR, Surendiran G, Goulet A, et al. The Role of dietary cholesterol in lipoprotein metabolism and related metabolic abnormalities: A mini-review. Crit Rev Food Sci Nutr 2016; 56(14): 2408-15.
58
2